Alport syndrome (AS) is a genetically heterogeneous disorder caused by mutations in type IV collagen genes, clinically characterized by progressive renal function deterioration. Despite advances in genetic screening technologies, cases resulting from non-canonical splice site variants remain diagnostically challenging, frequently leading to missed diagnoses or delayed therapeutic intervention. Here, we report a pediatric patient with AS and his mother, both harboring a novel splicing variant in